EUVIMEDEUVIMED entdecken
Fallbericht

Expanding the genetic and clinical spectrum of SORD ‐related peripheral neuropathy by reporting a novel variant c. 210T >G and evidence of subclinical muscle involvement

Lu Li iD, Yongzhi Xie iD, Sen Zeng, Xiaobo Li, Zhiqiang Lin, Shunxiang Huang, Huadong Zhao, Wanqian Cao, Lei Liu iD, Jun Liu, Pengfei Rong, Ruxu Zhang iD

Journal of the Peripheral Nervous System · 2023-12 · 28 (4) · 608-613

DOI: 10.1111/jns.12591 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 22.08.2023. Verfasst von Lu Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Third Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Hereditary Sensory and Motor Neuropathy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, the China International Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Biallelic variants in the sorbitol dehydrogenase ( SORD ) gene have been identified as the genetic cause of autosomal recessive (AR) peripheral neuropathy (PN) manifesting as Charcot–Marie–Tooth disease type 2 (CMT2) or distal hereditary motor neuropathy (dHMN). We aim to observe the genetic and clinical spectrum of a cohort of patients with SORD‐related PN (SORD‐PN).

Methods

A total of 107 patients with AR or sporadic CMT2/dHMN underwent molecular diagnosis by whole‐exome sequencing and subsequent Sanger sequencing validation. Available phenotypic data for SORD‐PN were collected and analyzed.

Results

Eleven (10.28%) of 107 patients were identified as SORD‐PN, including four with CMT2 and seven with dHMN. The SORD variant c.210 T > G;p.His70Gln in F‐d3 was firstly reported and subsequent analysis showed that it resulted in loss of SORD enzyme function. Evidence of subclinical muscle involvement was frequently detected in patients with SORD‐PN, including mildly to moderately elevated serum creatine kinase (CK) levels in 10 patients, myogenic electrophysiological changes in one patient, and muscle edema in five patients undergoing lower extremity MRI. Fasting serum sorbitol level was 88‐fold higher in SORD‐PN patients (9.69 ± 1.07 mg/L) than in healthy heterozygous subjects (0.11 ± 0.01 mg/L) and 138‐fold higher than in healthy controls (0.07 ± 0.02 mg/L).

Interpretation

The novel SORD variant c.210 T > G;p.His70Gln and evidence of subclinical muscle involvement were identified, which expanded the genetic and clinical spectrum of SORD‐PN. Subclinical muscle involvement might be a common but easily overlooked clinical feature. The serum CK and fasting serum sorbitol levels were expected to be sensitive biomarkers confirmed by follow‐up cohort study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Charcot-Marie-Tooth DiseaseHereditary Sensory and Motor NeuropathyHumansL-Iditol 2-DehydrogenaseFollow-Up StudiesMusclesSorbitolMutationPedigree

Stichwörter der Autor:innen

Charcot-Marie-Tooth disease type 2SORDdistal hereditary motor neuropathynovel variantperipheral neuropathysubclinical muscle involvement

Substanzen

L-Iditol 2-DehydrogenaseSorbitol

Autor:innen und Institutionen

  • Department of Neurology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Health Management Center, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China.

ORCID-Profile: Lu Li, Yongzhi Xie, Lei Liu, Ruxu Zhang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province
  • the China International Medical Foundation

Zitieren

APA

Li, L., Xie, Y., Zeng, S., Li, X., Lin, Z., Huang, S., Zhao, H., Cao, W., Liu, L., Liu, J., Rong, P., & Zhang, R. (2023). Expanding the genetic and clinical spectrum of SORD ‐related peripheral neuropathy by reporting a novel variant c. 210T >G and evidence of subclinical muscle involvement. Journal of the Peripheral Nervous System, 28(4), 608-613. https://doi.org/10.1111/jns.12591

Vancouver

Li L, Xie Y, Zeng S, Li X, Lin Z, Huang S, et al. Expanding the genetic and clinical spectrum of SORD ‐related peripheral neuropathy by reporting a novel variant c. 210T >G and evidence of subclinical muscle involvement. Journal of the Peripheral Nervous System. 2023;28(4):608-613. doi:10.1111/jns.12591

BibTeX
@article{Li2023,
  author = {Li, Lu and Xie, Yongzhi and Zeng, Sen and Li, Xiaobo and Lin, Zhiqiang and Huang, Shunxiang and Zhao, Huadong and Cao, Wanqian and Liu, Lei and Liu, Jun and Rong, Pengfei and Zhang, Ruxu},
  title = {Expanding the genetic and clinical spectrum of SORD ‐related peripheral neuropathy by reporting a novel variant c. 210T >G and evidence of subclinical muscle involvement},
  journal = {Journal of the Peripheral Nervous System},
  year = {2023},
  volume = {28},
  number = {4},
  pages = {608--613},
  doi = {10.1111/jns.12591}
}
Kostenlos starten →